ISDA

Entry Detail

PDB ID:

7NWB

Keywords:

Title:

CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC BRANCHED-CHAIN AMINOTRANSFERASE (BCAT1) IN COMPLEX WITH PLP AND INHIBITOR COMPOUND 1

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Escherichia coli BL21(DE3)

PDB Version:

Deposition Date:

2021-03-16

Release Date:

2022-11-02

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.64 Å

R-Value Free:

0.22

R-Value Work:

0.18

R-Value Observed:

0.18

Space Group:

P 1 21 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Branched-chain-amino-acid aminotransferase, cytosolic
Mutations:Ser379Arg
Chain IDs:A, B, C, D
Chain Length:389
Number of Molecules:4
Biological Source:Homo sapiens

UniProt ID:P54687 Pfam ID:PF01063 EC:2.6.1.42

Ligand Molecules

PLP

UTK

Primary Citation

BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe.

Gunther, J, Hillig, R.C, Zimmermann, K, Kaulfuss, S, Lemos, C, Nguyen, D, Rehwinkel, H, Habgood, M, Lechner, C, Neuhaus, R, Ganzer, U, Drewes, M, Chai, J, Bouche, L.Show

J.Med.Chem. 65 14366 14390 (2022)

PMID: 36261130 DOI: 10.1021/acs.jmedchem.2c00441

Abstact

The branched-chain amino acid transaminases (BCATs) are enzymes that catalyze the first reaction of catabolism of the essential branched-chain amino acids to branched-chain keto acids to form glutamate. They are known to play a key role in different cancer types. Here, we report a new structural class of BCAT1/2 inhibitors, (trifluoromethyl)pyrimidinediones, identified by a high-throughput screening campaign and subsequent optimization guided by a series of X-ray crystal structures. Our potent dual BCAT1/2 inhibitor BAY-069 displays high cellular activity and very good selectivity. Along with a negative control (BAY-771), BAY-069 was donated as a chemical probe to the Structural Genomics Consortium.

Legend

Protein

Chemical

Disease

Primary Citation of related structures